BlackRock Investment Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,608
Closed -$6K 4270
2016
Q1
$6K Hold
2,608
﹤0.01% 3803
2015
Q4
$6K Buy
2,608
+202
+8% +$816 ﹤0.01% 3850
2015
Q3
$11K Hold
2,406
﹤0.01% 3675
2015
Q2
$13K Buy
2,406
+806
+50% +$5K ﹤0.01% 3637
2015
Q1
$9K Buy
1,600
+343
+27% +$2.11K ﹤0.01% 3718
2014
Q4
$7K Hold
1,257
﹤0.01% 3825
2014
Q3
$11K Sell
1,257
-13
-1% -$128 ﹤0.01% 3654
2014
Q2
$17K Sell
1,270
-14,272
-92% -$140K ﹤0.01% 3463
2014
Q1
$186K Buy
15,542
+2,983
+24% +$39K ﹤0.01% 3241
2013
Q4
$190K Buy
+12,559
New +$160K ﹤0.01% 3224

Other funds holding BIND

BlackRock Investment Management's BIND Position: Q2 2016 in Review

BlackRock Investment Management sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 2,608 shares — an estimated $6K sold.

BlackRock Investment Management first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $190K in Q4 2013. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

  • BlackRock Investment Management reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 2,608 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $6K.
  • BlackRock Investment Management first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
  • BlackRock Investment Management's BIND THERAPEUTICS INC position peaked at $190K in Q4 2013.
  • 21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.